Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 63Leukemia, Myeloid, Acute 31Leukemia 25Carcinoma, Renal Cell 23Lymphoma 21Kidney Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Neoplasm Metastasis 14Lymphoma, Mantle-Cell 13Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Neuroblastoma 11Ovarian Neoplasms 10Congenital Abnormalities 10Lymphoma, B-Cell, Marginal Zone 9Breast Neoplasms 9Multiple Myeloma 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Recurrence 7Lymphoma, Large B-Cell, Diffuse 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Skin Neoplasms 5Pancreatic Neoplasms 5Myeloproliferative Disorders 5

Interventions

Cyclophosphamide 5Trabectedin 3Radiation Dose Hypofractionation 3fludarabine 2selinexor 1pazopanib 1palbociclib 1mirdametinib 1itacitinib 1fludarabine phosphate 1cytochrome C synthetase 1baricitinib 1aldesleukin 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Radiotherapy 1Proton Therapy 1Pioglitazone 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Interferon-gamma 1Ifosfamide 1INCB039110 1Doxorubicin 1Diathermy 1Biopsy 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liposarcoma, Myxoid × aldesleukin × Clear all
NCT03450122 2023-10-16

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

M.D. Anderson Cancer Center

Phase 1 Completed
15 enrolled
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡